Home › drug
 

Keywords :   


Tag: drug

RQx Pharmaceuticals And Genentech Enter Drug Discovery Collaboration To Develop Novel Drug Compounds

2013-02-27 02:22:35| drugdiscoveryonline Home Page

RQx Pharmaceuticals, Inc. today announced that it has entered into a drug discovery collaboration with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), for the discovery and development of novel drug compounds for an undisclosed target

Tags: enter develop drug collaboration

 

Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics

2013-02-27 02:15:32| drugdiscoveryonline News Articles

Based on its recent analysis of the aerosol drug delivery technology market, Frost & Sullivan recognizes KAER Biotherapeutics with the 2012 North America Frost & Sullivan Award for Technology Innovation for SUPRAER

Tags: methods delivery drug disease

 
 

Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics

2013-02-27 02:15:32| drugdiscoveryonline Home Page

Based on its recent analysis of the aerosol drug delivery technology market, Frost & Sullivan recognizes KAER Biotherapeutics with the 2012 North America Frost & Sullivan Award for Technology Innovation for SUPRAER

Tags: methods delivery drug disease

 

Oramed Pharmaceuticals Moves Forward With Investigational New Drug Application For Oral Insulin

2013-02-27 01:19:04| drugdiscoveryonline News Articles

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in communication with the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application for oral insulin

Tags: application forward drug oral

 

Oramed Pharmaceuticals Moves Forward With Investigational New Drug Application For Oral Insulin

2013-02-27 01:19:04| drugdiscoveryonline Home Page

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in communication with the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application for oral insulin

Tags: application forward drug oral

 

Sites : [265] [266] [267] [268] [269] [270] [271] [272] [273] [274] [275] [276] [277] [278] [279] [280] [281] [282] [283] [284] next »